12:00 AM
 | 
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lymphoseek tilmanocept regulatory update

FDA granted Fast Track designation to Lymphoseek tilmanocept to detect sentinel lymph nodes in patients with head and neck cancer. Navidea plans to submit an sNDA...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >